Fluid/function correlation using <scp>AI</scp>‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular <scp>AMD</scp> in a real‐world setting

The examination of IRF and SRF volumes significantly impacts BCVA in nAMD. The weaker association of CST highlights its limitations as a parameter of disease activity. These findings emphasize the necessity of distinct fluid volume quantification as a relevant surrogate for visual function loss or benefit in nAMD, with particular emphasis on treatment duration and fluid in regions beyond the central 1-mm.

Authors

Institutions

Publication Details

Journal
Acta Ophthalmologica
Published
2025-09-18
DOI
https://doi.org/10.1111/aos.70000
Citations
1
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fluid/function correlation using AI‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

Anna Eidenberger, Alexandra Mière, Catherine P Creuzot-Garcher, Virgínia Mares et al.
1 citations
Acta Ophthalmologica
Retinal Diseases and Treatments
1.71
article

Fluid/function correlation using AI‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

Anna Eidenberger, Alexandra Mière, Catherine P Creuzot-Garcher, Virgínia Mares, Stefan Sacu, Magdalena Baratsits, Ursula Schmidt‐Erfurth, Vincent Gualino, Markus Gumpinger, Benjamin Wolff, Georg Faustmann, Gregor S. Reiter, Laurent Kodjikian, Ulrike Scheschy, Sophie Frank‐Publig, Philipp Fuchs
article en
1 citations

Abstract

The examination of IRF and SRF volumes significantly impacts BCVA in nAMD. The weaker association of CST highlights its limitations as a parameter of disease activity. These findings emphasize the necessity of distinct fluid volume quantification as a relevant surrogate for visual function loss or benefit in nAMD, with particular emphasis on treatment duration and fluid in regions beyond the central 1-mm.

Acta Ophthalmologica
Université Claude Bernard Lyon 1 (FR), Austrian Research Institute for Artificial Intelligence (AT), Université Paris-Est Créteil (FR), Hospices Civils de Lyon (FR), Eye Center (SA), Clinique Claude-Bernard (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Horse Hospital (GB), Hôpital Intercommunal de Créteil (FR), Medical University of Vienna (AT)
Openalex Percentile: Top 14%
Retinal Diseases and Treatments
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.